BRPI0910403A8 - Uso de um agente traçador de mpi, e, método para o monitoramento visual de um produto biocompatível. - Google Patents

Uso de um agente traçador de mpi, e, método para o monitoramento visual de um produto biocompatível.

Info

Publication number
BRPI0910403A8
BRPI0910403A8 BRPI0910403A BRPI0910403A BRPI0910403A8 BR PI0910403 A8 BRPI0910403 A8 BR PI0910403A8 BR PI0910403 A BRPI0910403 A BR PI0910403A BR PI0910403 A BRPI0910403 A BR PI0910403A BR PI0910403 A8 BRPI0910403 A8 BR PI0910403A8
Authority
BR
Brazil
Prior art keywords
biocompatible
mpi
visual monitoring
products
tracking agent
Prior art date
Application number
BRPI0910403A
Other languages
English (en)
Inventor
Markov Denis
M B Boeve Hans
Original Assignee
Koninklijke Philips Electronics Nv
Koninklijke Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips Electronics Nv, Koninklijke Philips Nv filed Critical Koninklijke Philips Electronics Nv
Publication of BRPI0910403A2 publication Critical patent/BRPI0910403A2/pt
Publication of BRPI0910403A8 publication Critical patent/BRPI0910403A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

USO DE UM AGENTE TRAÇADOR DE MPI, E, MÉTODO PARA O MONITORAMENTO VISUAL DE UM PRODUTO BIOCOMPATÍVEL. A presente invenção refere-se aos materiais e métodos para a formação de imagem não invasiva de produtos biocompatíveis. Os produtos biocompatíveis são fornecidos os quais podem ser visualizadas in vivo e in vitro, utilizando métodos de formação de imagem com partículas magnéticas. Observou-se que estes materiais podem ser empregados para o monitoramento do desenvolvimento, remodelação ou degradação de produtos biocompatíveis. Em outro aspecto, os produtos da invenção permitem o rastreamento de liberação da substância e podem ser usados para visualizar a liberação direcionada de agentes ativos.
BRPI0910403A 2008-04-03 2009-03-26 Uso de um agente traçador de mpi, e, método para o monitoramento visual de um produto biocompatível. BRPI0910403A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08103358 2008-04-03
PCT/IB2009/051274 WO2009122330A2 (en) 2008-04-03 2009-03-26 Biocompatible products for magnetic particle imaging

Publications (2)

Publication Number Publication Date
BRPI0910403A2 BRPI0910403A2 (pt) 2015-08-11
BRPI0910403A8 true BRPI0910403A8 (pt) 2015-11-10

Family

ID=40636921

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910403A BRPI0910403A8 (pt) 2008-04-03 2009-03-26 Uso de um agente traçador de mpi, e, método para o monitoramento visual de um produto biocompatível.

Country Status (7)

Country Link
US (1) US20110027189A1 (pt)
EP (1) EP2274024B1 (pt)
JP (1) JP2011516462A (pt)
CN (1) CN101980730B (pt)
BR (1) BRPI0910403A8 (pt)
RU (1) RU2496525C2 (pt)
WO (1) WO2009122330A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2575913B1 (en) 2010-05-25 2018-07-25 Cook Biotech Incorporated Methods, substrates, and systems useful for cell seeding of medical grafts
US8798716B1 (en) * 2011-11-03 2014-08-05 Solstice Corporation Fiducial markers and related methods
US20150374855A1 (en) * 2013-02-20 2015-12-31 Topass Gmbh Oral contrast medium for the diagnostic investigation of the gastrointestinal tract by means of mpi
TWI459966B (zh) * 2013-03-06 2014-11-11 Univ Nat Chiao Tung 奈米粒子藥物載體、藥物組合物及其製造方法
WO2015095380A1 (en) * 2013-12-17 2015-06-25 Kassab Ghassan S Devices, systems and methods for tissue engineering of luminal grafts
CZ2014451A3 (cs) * 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
WO2017152127A1 (en) * 2016-03-03 2017-09-08 Amrita Vishwa Vidyapeetham Mri and ct contrast-enabled composite implants for image-guided tissue regeneration and therapy
CN109125924A (zh) * 2018-08-14 2019-01-04 上海白衣缘生物工程有限公司 一种生物套在电子器械心脏植入方面的应用
CN111870706B (zh) * 2020-08-24 2021-12-14 中国科学院长春应用化学研究所 一种可mri示踪显影的细胞微载体及制备方法
WO2023146474A2 (en) * 2022-01-27 2023-08-03 Agency For Science, Technology And Research A method of imaging an inanimate structural implant in a tissue
CN118416297A (zh) * 2023-05-11 2024-08-02 刘佳东 一种聚左旋乳酸粉剂及其制备方法和使用方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98744A0 (en) * 1990-07-06 1992-07-15 Gen Hospital Corp Method of studying biological tissue using monocrystalline particles
DE19921088C2 (de) * 1999-04-30 2003-08-07 Magforce Applic Gmbh Stent zur Offenhaltung gangartiger Strukturen
US7169618B2 (en) * 2000-06-28 2007-01-30 Skold Technology Magnetic particles and methods of producing coated magnetic particles
DE10151778A1 (de) * 2001-10-19 2003-05-08 Philips Corp Intellectual Pty Verfahren zur Ermittlung der räumlichen Verteilung magnetischer Partikel
US6962685B2 (en) * 2002-04-17 2005-11-08 International Business Machines Corporation Synthesis of magnetite nanoparticles and the process of forming Fe-based nanomaterials
US7101394B2 (en) * 2002-05-02 2006-09-05 Boston Scientific Scimed, Inc. Energetically-controlled delivery of biologically active material from an implanted medical device
DE10238853A1 (de) 2002-08-24 2004-03-04 Philips Intellectual Property & Standards Gmbh Verfahren zur lokalen Erwärmung mit magnetischen Partikeln
US9603544B2 (en) 2003-04-15 2017-03-28 Koninklijke Philips N.V. Method of determining state variables and changes in state variables
EP1615558B1 (en) * 2003-04-15 2012-02-22 Philips Intellectual Property & Standards GmbH Method for the spatially resolved determination of physical, chemical and biological properties or state variables
US20060025713A1 (en) * 2003-05-12 2006-02-02 Alex Rosengart Magnetic particle-based therapy
WO2005046733A1 (en) * 2003-11-17 2005-05-26 Philips Intellectual Property & Standards Gmbh Contrast agent for medical imaging techniques and usage thereof
US20060141149A1 (en) * 2004-12-29 2006-06-29 Industrial Technology Research Institute Method for forming superparamagnetic nanoparticles
US20060204445A1 (en) * 2005-03-11 2006-09-14 Anthony Atala Cell scaffold matrices with image contrast agents
EP1738774A1 (de) * 2005-06-29 2007-01-03 Schering AG Magnetische Eisenoxidpartikel enthaltende Zusammensetzungen und deren Verwendung in bildgebenden Verfahren
EP1738773A1 (de) 2005-06-29 2007-01-03 Schering AG Magnetische Eisenoxidpartikel enthaltende Zusammensetzung und deren Vervendung in bildgebenden Verfahren

Also Published As

Publication number Publication date
WO2009122330A2 (en) 2009-10-08
CN101980730B (zh) 2015-02-25
JP2011516462A (ja) 2011-05-26
BRPI0910403A2 (pt) 2015-08-11
EP2274024B1 (en) 2013-05-15
WO2009122330A3 (en) 2010-07-29
US20110027189A1 (en) 2011-02-03
RU2496525C2 (ru) 2013-10-27
RU2010144967A (ru) 2012-05-10
EP2274024A2 (en) 2011-01-19
CN101980730A (zh) 2011-02-23

Similar Documents

Publication Publication Date Title
BRPI0910403A8 (pt) Uso de um agente traçador de mpi, e, método para o monitoramento visual de um produto biocompatível.
ES2544967T3 (es) Formulación y método para la prevención y el tratamiento de las metástasis óseas o de otras enfermedades óseas
PH12021550756A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
WO2009114776A3 (en) Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
BRPI1012602A8 (pt) Linha que possui estruturas revestidas para ancoragem para ancoragem em tecidos biológicos e sistema para fechamento de ferida e kit de peças cirúrgicas
BR112013002601A2 (pt) corticosteróides para o tratamento de dor em articulação
MY148461A (en) Heteroaryl amide analogues as p2x7 antagonists
MX2011008448A (es) Uso de ester etilico del acido eisosapentaenoico para tratar hipertrigliceridemia.
EA201270050A1 (ru) Нанодисперсия лекарственного средства и способ ее получения
BR112015010395A8 (pt) Composição para tratamento da pele com enxágue
MX2018011832A (es) Metodos y composiciones para uso en diagnostico de pacientes con cancer.
BR112012010995A2 (pt) revestimentos e métodos de revestimento de agulhas cirúrgicas
BRPI1014595A2 (pt) procedimento de obtenção de novos derivados naftaleno para o diagnóstico in vivo de doença de alzheimer
BR112013000433A2 (pt) diagnóstico e tratamento de câncer de mama
BR112013000776A2 (pt) método e formulação para tratamento de deficiência de ácido siálico
BR112012011000A2 (pt) revestimentos e métodos de revestimento de agulhas cirúrgicas
PH12015502556A1 (en) Modified release formulation
EP2593102A4 (en) OXAZOLE DERIVATIVES SUITABLE AS FAAH MODULATORS
SG10201804772UA (en) Method of imaging living tissue
BR112012010994A2 (pt) revestimentos e métodos de revestimento de agulhas cirúrgicas
FR2982487B1 (fr) Utilisation d'une association de trois principes actifs pour la reconstruction du tissu adipeux et la lutte contre les signes du vieillissement cutane
BR112019012084A2 (pt) uso médico de interferon-lambda para o tratamento de fibrose
CY1118036T1 (el) Βελτιστοποιημενη συνθεση καθαρων μη-πολυμορφικων, κρυσταλλικων χολικων οξεων με καθορισμενο μεγεθος σωματιδιων
Jonaitis et al. Concerns regarding nano-sized titanium dioxide dermal penetration and toxicity study
MA34291B1 (fr) Compositions et méthodes de diagnostic et de traitement d'une tumeur

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: KONINKLIJKE PHILIPS N.V. (NL)

B25G Requested change of headquarter approved

Owner name: KONINKLIJKE PHILIPS N.V. (NL)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]